Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $649.43 | 37 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $294.04 | 13 | $0 (2021) |
| Amgen Inc. | $97.16 | 6 | $0 (2022) |
| GlaxoSmithKline, LLC. | $50.20 | 3 | $0 (2018) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $35.12 | 2 | $0 (2018) |
| Novo Nordisk Inc | $32.70 | 3 | $0 (2018) |
| ABBVIE INC. | $30.92 | 2 | $0 (2022) |
| Takeda Pharmaceuticals America, Inc. | $26.20 | 2 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $24.31 | 2 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $18.35 | 1 | $0 (2017) |
| SANOFI PASTEUR INC. | $14.00 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $39.32 | 2 | Amgen Inc. ($21.15) |
| 2021 | $46.98 | 3 | Allergan, Inc. ($18.09) |
| 2020 | $31.07 | 2 | Allergan, Inc. ($31.07) |
| 2019 | $43.57 | 3 | Allergan Inc. ($29.57) |
| 2018 | $145.66 | 10 | Amgen Inc. ($59.87) |
| 2017 | $342.83 | 17 | Allergan Inc. ($202.75) |
All Payment Transactions
37 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/17/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: NEUROSCIENCE | ||||||
| 02/04/2022 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: Bone Health | ||||||
| 11/30/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: NEUROSCIENCE | ||||||
| 07/21/2021 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: Bone Health | ||||||
| 04/14/2021 | Allergan, Inc. | NATRELLE SALINE-FILLED BREAST IMPLANTS (Device) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: PLASTICS | ||||||
| 12/17/2020 | Allergan, Inc. | NATRELLE (Device) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: PLASTICS | ||||||
| 07/28/2020 | Allergan, Inc. | NATRELLE (Device) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: PLASTICS | ||||||
| 10/02/2019 | Allergan Inc. | NATRELLE (Device) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: PLASTICS | ||||||
| 08/23/2019 | SANOFI PASTEUR INC. | FLUZONE QUADRIVALENT (Drug), FLUBLOK QUADRIVALENT, FLUZONE HIGH-DOSE | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: VACCINES | ||||||
| 03/26/2019 | Allergan Inc. | ALLODERM (Device) | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: PLASTIC SURGERY | ||||||
| 09/12/2018 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: Neuroscience | ||||||
| 07/31/2018 | Allergan Inc. | NATRELLE (Device) | Food and Beverage | In-kind items and services | $12.56 | General |
| Category: PLASTICS | ||||||
| 07/18/2018 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: RESPIRATORY | ||||||
| 05/30/2018 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Endocrinology | ||||||
| 05/30/2018 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Endocrinology | ||||||
| 05/22/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.10 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/16/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.02 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/09/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, JANUMET XR | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/03/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $10.82 | General |
| Category: Diabetes | ||||||
| 04/11/2018 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: Endocrinology | ||||||
| 12/13/2017 | GlaxoSmithKline, LLC. | BOOSTRIX (Biological), FLULAVAL, FLUARIX | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: VACCINES | ||||||
| 11/08/2017 | Novo Nordisk Inc | Victoza (Drug) | Food and Beverage | In-kind items and services | $11.12 | General |
| Category: Diabetes | ||||||
| 10/26/2017 | Allergan Inc. | NATRELLE-INSPIRA (Device) | Food and Beverage | In-kind items and services | $6.02 | General |
| Category: PLASTICS | ||||||
| 08/23/2017 | Allergan Inc. | NATRELLE-INSPIRA (Device) | Food and Beverage | In-kind items and services | $138.43 | General |
| Category: PLASTICS | ||||||
| 06/26/2017 | Allergan Inc. | NATRELLE-INSPIRA (Device) | Food and Beverage | In-kind items and services | $12.56 | General |
| Category: PLASTICS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 204 | 224 | $31,162 | $20,612 |
| 2022 | 11 | 508 | 749 | $76,245 | $46,266 |
| 2021 | 14 | 525 | 623 | $63,875 | $41,809 |
| 2020 | 12 | 433 | 535 | $57,319 | $31,148 |
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 24 | 24 | $7,080 | $6,722 | 94.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 42 | 42 | $7,272 | $5,387 | 74.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 64 | 79 | $8,690 | $3,604 | 41.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 34 | 39 | $6,240 | $3,234 | 51.8% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 16 | 16 | $1,280 | $1,077 | 84.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 24 | 24 | $600.00 | $588.00 | 98.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 113 | 113 | $19,566 | $14,979 | 76.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 126 | 232 | $25,520 | $14,111 | 55.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 59 | 87 | $13,920 | $7,201 | 51.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 34 | 34 | $3,050 | $2,327 | 76.3% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 12 | 12 | $3,065 | $2,038 | 66.5% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 40 | 54 | $4,320 | $1,651 | 38.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 28 | 29 | $1,885 | $1,228 | 65.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 13 | 101 | $2,525 | $973.20 | 38.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 34 | 34 | $850.00 | $833.50 | 98.1% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 26 | 30 | $900.00 | $704.19 | 78.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 23 | 23 | $644.00 | $219.77 | 34.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 105 | 105 | $18,181 | $14,188 | 78.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 100 | 165 | $18,128 | $10,414 | 57.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 57 | 85 | $13,600 | $8,447 | 62.1% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 42 | 42 | $3,360 | $2,741 | 81.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 32 | 34 | $3,689 | $1,849 | 50.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 45 | 45 | $1,125 | $765.45 | 68.0% |
| 87428 | Sarscov & inf vir a&b ag ia | Office | 2021 | 12 | 12 | $960.00 | $763.08 | 79.5% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 18 | 18 | $840.00 | $634.62 | 75.6% |
About Dr. Kevin Keller, MD
Dr. Kevin Keller, MD is a Family Medicine healthcare provider based in Midlothian, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1982657615.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kevin Keller, MD has received a total of $649.43 in payments from pharmaceutical and medical device companies, with $39.32 received in 2022. These payments were reported across 37 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($649.43).
As a Medicare-enrolled provider, Keller has provided services to 1,670 Medicare beneficiaries, totaling 2,131 services with total Medicare billing of $139,835. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Midlothian, VA
- Active Since 05/17/2006
- Last Updated 08/12/2010
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1982657615
Products in Payments
- NATRELLE-INSPIRA (Device) $157.01
- NATRELLE (Device) $75.70
- Prolia (Biological) $45.83
- EVENITY (Biological) $37.29
- XIFAXAN (Drug) $35.12
- QULIPTA (Drug) $30.92
- Victoza (Drug) $21.88
- BOOSTRIX (Biological) $20.88
- NAMZARIC (Drug) $19.46
- ENTRESTO (Drug) $18.35
- NATRELLE SALINE-FILLED BREAST IMPLANTS (Device) $18.09
- Amitiza (Drug) $14.37
- ALLODERM (Device) $14.19
- Aimovig (Biological) $14.04
- FLUZONE QUADRIVALENT (Drug) $14.00
- JANUVIA (Drug) $13.74
- NUCALA (Biological) $13.55
- TOUJEO (Drug) $12.79
- Trintellix (Drug) $11.83
- Ozempic (Drug) $10.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Midlothian
Donald Sanders, M.d, M.D
Family Medicine — Payments: $18,297
Joseph Goddard, M.d, M.D
Family Medicine — Payments: $17,178
Dr. Joseph Castro, D.o, D.O
Family Medicine — Payments: $14,548
William Morrissette, M.d, M.D
Family Medicine — Payments: $13,896
Dr. Laura Aisenberg, M.d, M.D
Family Medicine — Payments: $13,402
Damian Covington, M. D, M. D
Family Medicine — Payments: $12,759